Alligator Bioscience Q3 2024: Approaching the Decisive Moment - Redeye

Redeye comments on Alligator's Q3 report. The main event since our last update was the ALG.APV-527 phase I readout. Considering the limited runway and intention to begin a phase III study by mid-2025, Alligator will have to sign a deal in the very near future.

Länk till analysen i sin helhet: https://www.redeye.se/research/1045976/alligator-bioscience-q3-2024-approaching-the-decisive-moment?utm_source=finwire&utm_medium=RSS